Suhayl Dhib-Jalbut, MD, Neurology, New Brunswick, NJ, Robert Wood Johnson University Hospital

SuhaylSamihDhib-JalbutMD

NeurologyNew Brunswick, NJ

Neuroimmunology/Multiple Sclerosis

Professor and Chairman, Department of Neurology, Rutgers-RWJ Medical School

Dr. Dhib-Jalbut is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Dhib-Jalbut's full profile

Already have an account?

Education & Training

  • University Hospital - University of Cincinnati College of Medicine
    University Hospital - University of Cincinnati College of MedicineResidency
  • American University of BeirutOtherTraining
  • American University of Beirut Faculty of Medicine
    American University of Beirut Faculty of MedicineMedicalSchool

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2003 - 2021
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Edward J. Ill Excellence in Medicine Award for Outstanding Medical Research Scientist 2013
  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
  • Medical Excellence Award The National Multiple Sclerosis Society-NJ Metro Chapter, 2009
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Current use of biomarkers to guide MS therapies  
    Dhib-Jalbut SS, IJMSC, 10/1/2013
  • From emerging agents to biomarkers: Integrating scientific advances into MS management  
    Dhib-Jalbut SS, Markowitz CE, Miller A, IJMSC, 1/1/2013
  • Immune response during Interferon-beta-1b treatment in patients with multiple sclerosis who experienced relapses and those who were relapse free in the START study  
    Dhib-Jalbut SS, Sumandeep S, Valenzuela RM, Ito K, Patel P, Rametta M, J Neuroimmunol, 1/1/2013
  • Join now to see all

Lectures

  • Minimizing Risks and Maximizing Efficacy for Management of Multiple Sclerosis 
    CMEducation Resources, LLC, San Jose, California - 4/20/2013
  • Minimizing Risks and Maximizing Efficacy for Management of Multiple Sclerosis 
    CMEducation Resources, LLC, Dallas, Texas - 4/13/2013
  • Minimizing Risks and Maximizing Efficacy for Management of Multiple Sclerosis 
    CMEducation Resources, LLC, Atlanta, Georgia - 4/6/2013

Press Mentions

  • What to Expect at CMSC 2016May 31, 2016

Grant Support

  • Bdnf-Engineered Stem Cell Mediated Neuroprotection In EAENational Institute Of Neurological Disorders And Stroke2009–2010
  • Interferon-B And Copolymer-I In Multiple Sclerosis.National Institute Of Neurological Disorders And Stroke2003
  • Interferon-B And Copolymer-I In Multiple Sclerosis.National Institute Of Neurological Disorders And Stroke1999–2002
  • Regulation &Function Of Class-Ii HLA Molecules In Measles Infected Human GliaNational Institute Of Neurological Disorders And Stroke1992–1996

Hospital Affiliations